sales@intentmarketresearch.com

  +1 463-583-2713

RNA Analysis Market By Product & Service (Reagents/Consumables, Instrument, Software, Services), By Technology (Polymerase Chain Reaction, Microarray, Sequencing, RNA Interference), By Application (Drug Discovery & Development, Clinical Diagnostics, Toxicogenomics, Transcriptome Analysis), By End-user (Pharmaceutical & Biotechnology Company, Hospitals & Diagnostic Centers, Academic & Research Institutes, Clinical Research Organization) and By Region; Global Insights & Forecast (2024 – 2030)

Published: February, 2024  
|   Report ID: HC3072  
|   Life Sciences & Healthcare

According to Intent Market Research, the RNA Analysis Market is expected to grow from USD 5.5 billion in 2023-e at a CAGR of 10.8% to touch USD 10.3 billion by 2030. The RNA analysis market is competitive, the prominent players in the global market include Agilent, Basepair, BioMérieux, Bio-Rad Laboratories, Eurofins, GenXPro, Illumina, Promega Corporation, Qiagen, Roche, Thermo Fisher Scientific, amongst others. The market is thriving due to the rising interest for personalized medicines across the globe.

RNA Analysis Market

Click here to: Get FREE Sample Pages of this Report

COVID-19 Pandemic and Post-Pandemic Transitions have significantly boosted RNA Analysis Market

The emergence of the COVID-19 pandemic significantly influenced the market, with a surge in demand for testing and diagnosis due to the severity of the SARS-CoV-2 virus infection. The pandemic prompted increased research to unravel the virus's genetic makeup, driving demand for next-generation sequencing (NGS) and polymerase chain reaction (PCR). While the initial impact was favorable, with heightened market activity during the pandemic, the current post-pandemic phase has led to a slight loss of momentum.

Increasing Investments in Pharmaceuticals for Personalized Medicine is Driving the Market

The RNA analysis market is experiencing a surge in interest due to the growing demand for personalized medicine. This is accompanied by increased investments in pharmaceutical and biotechnology research, emphasizing the industry's commitment to innovative healthcare solutions.

Role of Reagents and Consumables Supply in Fueling RNA Analysis Advancements

This segment involves the supply of chemical and biological substances essential for RNA analysis, including primers, probes, enzymes, and other consumables. The demand for reagents/consumables is directly correlated with the overall adoption and usage of RNA analysis technologies. As researchers and laboratories engage in RNA analysis processes, the consumption of reagents and consumables increases.

According to the World Health Organization's February 2022 update, cancer stands as a major global cause of mortality, with cancer-causing infections such as human papillomavirus (HPV) and hepatitis contributing to around 30% of cases in low- and lower-middle-income countries. Given the substantial burden of cancer and infectious diseases, there is an escalating demand for diagnosis in medical specialties and diagnostic care centres, projecting substantial growth for the reagents/consumables segment throughout the forecast period.

Transformative Impact of Advanced PCR Technology in the RNA Analysis Market

PCR is a fundamental technology in RNA analysis, facilitating the amplification of RNA sequences for further study. Advancements in PCR technology, such as the introduction of real-time PCR, contribute significantly to the evolution of this segment. Real-time PCR enables researchers to monitor the amplification process in real time, providing quantitative data and enhancing the precision of RNA analysis. The continuous improvement and innovation in PCR technology drive market growth by offering more efficient and accurate tools for RNA analysis applications.

Advanced PCR Technology in the RNA Analysis Market

Drug Discovery Excellence in Identifying Potential Drug Targets is Boosting the Market

RNA analysis is a cornerstone in drug discovery and development processes. It plays a pivotal role in identifying potential drug targets and understanding gene expression patterns associated with diseases. The pharmaceutical industry heavily relies on RNA analysis to discover new therapeutic targets, assess drug efficacy, and optimize treatment strategies. The demand for RNA analysis tools and services in the drug discovery and development segment is instrumental in shaping the market landscape.

RNA Analysis Tools and Services Taking Center Stage in Pharmaceutical and Biotechnology Frontiers

The demand for RNA analysis tools and services is particularly high in the pharmaceutical and biotechnology sectors. These industries are at the forefront of drug development and research activities, relying on RNA analysis for various applications, including target identification, biomarker discovery, and understanding disease mechanisms.

Europe Market Thrives Due to the Continuous Technological Advancements in Region

The RNA analysis market in Europe experiences growth driven by active research, technological advancements in next-generation sequencing, government funding, collaborative efforts, and expanding clinical applications. Institutions and companies engage in RNA-related research, contributing to advancements in genomics and transcriptomics.

For instance, the market segment's growth is further propelled by strategic product launches from key players. For instance, in March 2021, PCR Biosystems, a UK-based company introduced the IsoFast BST Polymerase reagents range for rapid, robust, and sensitive RNA amplification. These product approvals are poised to significantly contribute to the segment's growth during the forecast period.

Major Industry Players are Enhancing their Positions in the RNA Analysis Market

The market is characterized by intense competition due to the presence of numerous international and domestic players. The RNA analysis market, in particular, is dominated by key players such as Agilent, Basepair, BioMérieux, Bio-Rad Laboratories, Eurofins, GenXPro, Illumina, Promega Corporation, Qiagen, Roche, Thermo Fisher Scientific, amongst others.  

Pioneering Product Developments and Strategic Acquisitions Drive Growth in the RNA Analysis Industry

The integration of personalized medicine into mainstream clinical practice has revolutionized disease detection, classification, and treatment. This paradigm shift is particularly evident in oncology, where tailored medications, therapies, and diagnostic tests have become more prevalent. As per the American Cancer Society, the increasing burden of cancer worldwide, with an estimated 29.0 million cases by 2040, contributes to the growing demand for RNA analysis products to develop innovative precision medicines for cancer.

Market players are actively contributing to growth through product developments and innovations. For instance, in April 2022, Lexogen's introduced CORALL RNA-Seq V2 whole transcriptome library prep kit, a cutting-edge technology enabling comprehensive RNA molecule determination in samples. Additionally, a strategic initiative in January 2021 by Merck acquired AmpTec to enhance mRNA development capabilities. Through the acquisition, Merck will be better equipped to research, develop, and produce mRNA for its clients' usage in COVID-19 and other disease-specific therapies, diagnostics, and vaccinations, which are anticipated to bolster market growth.

Click here to: Get your custom research report today

RNA Analysis Market Coverage

The report provides key insights into the RNA analysis market, and it focuses on technological developments, trends, and initiatives taken by the government in this sector. The report delves into market drivers, restraints, and opportunities, and analyses key players and the competitive landscape within the market. The report offers the market size and forecasts for the RNA analysis market in value (USD billion) for all the above segments.

RNA Analysis Market Coverage

Report Scope

Report Features

Description

Market Size (2023-e)

USD 5.5 billion

Forecast Revenue (2030)

USD 10.3 billion

CAGR (2024-2030)

10.8%

Base Year for Estimation

2023-e

Historic Year

2022

Forecast Period

2024-2030

Report Coverage

Market Forecast, Market Dynamics, Competitive Landscape, Recent Developments

Segments Covered

By Product & Service (Reagents/Consumables, Instrument, Software, Services), By Technology (Polymerase Chain Reaction, Microarray, Sequencing, RNA Interference, Others), By Application         (Drug Discovery & Development, Clinical Diagnostics, Toxicogenomics, Transcriptome Analysis, Others), By End-Use Industry (Pharmaceutical & Biotechnology Company, Hospitals & Diagnostic Centers, Academic & Research Institutes, Clinical Research Organization)

Regional Analysis

North America (US, Canada), Europe (Germany, France, UK, Spain, Italy), Asia-Pacific (China, Japan, South Korea, India), Latin America (Brazil, Mexico, Argentina), Middle East and Africa (Saudi Arabia, South Africa, Turkey, United Arab Emirates)

Competitive Landscape

Agilent, Basepair, BioMérieux, Bio-Rad Laboratories, Eurofins, GenXPro, Illumina, Promega Corporation, Qiagen, Roche, Thermo Fisher Scientific, amongst others

Customization Scope

Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements.

Purchase Options

We have three licenses to opt for Single User License, Multi-User License (Up to 5 Users), Corporate Use License (Unlimited User and Printable PDF)

1.Introduction

1.1.Study Assumptions and Market Definition

1.2.Scope of the Study

2.Research Methodology

3.Executive Summary

4.Market Dynamics

4.1.Market Growth Drivers

4.1.1.Growing Interest in Personalized Medicine

4.1.2.Expanding Applications of RNA Sequencing

4.1.3.Rising Investments in Pharmaceutical and Biotechnology

4.2.Market Growth Restraints

4.2.1.Data Analysis Challenges

4.3.Market Growth Opportunities

4.3.1.Promising Expansion Opportunities in Emerging Markets

4.3.2.Growing Utilization in Toxicogenomics Applications

4.4.Pestle Analysis

4.5.Porter’s Five Forces Analysis

5.Market Outlook

5.1.Overview (Industry Snapshot)

5.2.Technology Analysis

5.3.Supply Chain Analysis

5.4.Value Chain Analysis

5.5.Regulatory Analysis

5.6.Ecosystem Analysis

5.7.Patent Analysis

5.8.Trade Analysis

5.9.Trends/Disruptions

6.Market Segment Outlook (Market Size & Forecast: USD Billion, 2024 – 2030)

6.1.Segment Synopsis

6.2.By Product & Service

6.2.1.Reagents/Consumables

6.2.2.Instruments

6.2.3.Software

6.2.4.Services

6.3.By Technology

6.3.1.Polymerase Chain Reaction (PCR)

6.3.2.Microarrays

6.3.3.Sequencing

6.3.4.RNA Interference

6.3.5.Others

6.4.By Application

6.4.1.Drug Discovery & Development

6.4.2.Toxicogenomics

6.4.3.Clinical Diagnostics

6.4.4.Transcriptome Analysis

6.4.5.Others

6.5.By End-Use

6.5.1.Pharmaceutical Companies

6.5.2.Hospitals & Diagnostic Centers

6.5.3.Research Institutes

6.5.4.Clinical Research Organizations

 

7.Regional Outlook (Market Size & Forecast: USD Billion, 2024 – 2030)

7.1.Global Market Synopsis

7.2.North America

7.2.1.North America RNA Analysis Market Outlook

7.2.1.1.US RNA Analysis Market, By Product & Service

7.2.1.2.US RNA Analysis Market, By Technology

7.2.1.3.US RNA Analysis Market, By Application

7.2.1.4.US RNA Analysis Market, By End-Use

*Note: Cross-segmentation by segments for each country will be covered as shown above.

7.2.2.Canada

7.3.Europe

7.3.1.Europe RNA Analysis Market Outlook

7.3.1.1.Germany

7.3.1.2.UK

7.3.1.3.France

7.3.1.4.Spain

7.3.1.5.Italy

7.4.Asia-Pacific

7.4.1.Asia-Pacific RNA Analysis Market Outlook

7.4.1.1.China

7.4.1.2.India

7.4.1.3.Japan

7.4.1.4.South Korea

7.4.1.5.Australia

7.5.Latin America

7.5.1.Latin America RNA Analysis Market Outlook

7.5.1.1.Mexico

7.5.1.2.Brazil

7.6.Middle East & Africa

7.6.1.Middle East & Africa RNA Analysis Market Outlook

7.6.1.1.Saudi Arabia

7.6.1.2.UAE

8.Competitive Landscape

8.1.Market Share Analysis

8.2.Volume Output Analysis

8.3.Company Strategy Analysis

8.4.Competitive Matrix

9.Company Profiles

9.1. Agilent Technologies

9.1.1.Company Synopsis

9.1.2.Company Financials

9.1.3.Product/Service Portfolio

9.1.4.Recent Developments

9.1.5.Analyst Perception

*Note: All the companies in the section 9.1 will cover same sub-chapters as above.

9.2.Basepair

9.3.BioMérieux

9.4.Bio-Rad Laboratories

9.5.Eurofins

9.6.GenXPro

9.7.Illumina

9.8.Promega Corporation

9.9.Qiagen

9.10.Roche

9.11.Thermo Fisher Scientific

 

Let us connect with you TOC

I have read the Terms & Conditions and Privacy Policy I agree to its terms

Intent Market Research employs a rigorous methodology to minimize residual errors by carefully defining the scope, validating findings through primary research, and consistently updating our in-house database. This dynamic approach allows us to capture ongoing market fluctuations and adapt to evolving market uncertainties.

The research factors used in our methodology vary depending on the specific market being analyzed. To begin with, we incorporate both demand and supply side information into our model to identify and address market gaps. Additionally, we also employ approaches such as Macro-Indicator Analysis, Factor Analysis, Value Chain-Based Sizing, and forecasting to further increase the accuracy of the numbers and validate the findings.

Research Approach

RNA Analysis Market - Research Approach

  • Secondary Research Approach: During the initial phase of the research process, we acquire and accumulate extensive data continuously. This data is carefully filtered and validated through a variety of secondary sources.
  • Primary Research Approach: Following the consolidation of data gathered through secondary research, we initiate a validation and verification process to verify all the market numbers and assumptions by engaging with the subject matter experts.

Data Collection, Analysis and Interpretation:

RNA Analysis Market - Data Collection, Analysis and Interpretation

Research Methodology

Our market research methodology utilizes both top-down and bottom-up approaches to segment and estimate quantitative aspects of the market. We also employ multi-perspective analysis, examining the market from distinct viewpoints.

RNA Analysis Market - Research Methodology

RNA Analysis Market Infoghraphics

Let us connect with you


I have read the Terms & Conditions and Privacy Policy I agree to its terms
Available Formats
REPORT BUYING OPTIONS


Buy Now